Prostate Cancer
Statin use and incident prostate cancer risk: Does the statin brand matter? A population-based cohort study - Abstract
October 24, 2013
Transperineal template-guided biopsy for diagnosis of prostate cancer in patients with at least two prior negative biopsies - Abstract
October 24, 2013
Time to nadir PSA: Of popes and PSA-The immortality bias - Abstract
October 23, 2013
Combined treatment effects of radiation and immunotherapy: Studies in an autochthonous prostate cancer model - Abstract
October 23, 2013
Mortality and complications following prostate biopsy in the PLCO Cancer Screening trial - Abstract
October 23, 2013
Indications, results and safety profile of transperineal sector biopsies of the prostate: A single centre experience of 634 cases - Abstract
October 23, 2013
Prostate-specific antigen velocity risk count predicts biopsy reclassification for men with very-low-risk prostate cancer - Abstract
October 23, 2013
Prostate cancer disease characteristics for foreign-born South Asian men living in the United States - Abstract
October 23, 2013
Diagnostic dilemma in histopathology report following robot assisted laparoscopic prostatectomy: Tumour 'hide and seek' - Abstract
October 23, 2013
UroToday® introduces Urology TUBE™ to provide state-of-the-art delivery of rich media content to its global readership
October 22, 2013
Bladder outlet obstruction in men with castration-resistant prostate cancer - Abstract
October 21, 2013
PSA doubling time as a progression criterion in an active surveillance programme for patients with localised prostate cancer - Abstract
October 21, 2013